title: Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.
abstract: A 14-year-old Saudi boy with cherry red spot-myoclonus syndrome and documented neuraminidase deficiency responded well to titrated doses of 5-hydroxytryptophan as an add-on treatment.
authors.affiliation: Division of Neurology, King Khalid University Hospital, Riyadh, Saudi Arabia.
authors.forename: G
authors.initials: G
authors.lastname: Gascon
authors.forename: B
authors.initials: B
authors.lastname: Wallenberg
authors.forename: A K
authors.initials: AK
authors.lastname: Daif
authors.forename: P
authors.initials: P
authors.lastname: Ozand
mesh_terms: D006916:5-Hydroxytryptophan / Q000627:therapeutic use*; D000293:Adolescent; D005260:Female; D006801:Humans; D008297:Male; D009207:Myoclonus / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D009439:Neuraminidase / Q000172:deficiency*; D010375:Pedigree; D013577:Syndrome
chemical_list: D006916:5-Hydroxytryptophan; D009439:Neuraminidase